Seon-Hyeong Lee

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Diabetic Retinopathy

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Eun-Sil Lee, Nayeon Kim, Joon Hee Kang, Aizhan Abdildinova, Seon-Hyeong Lee, Myung Hwi Lee, Nam Sook Kang, Tae-Sung Koo, Soo-Youl Kim, Young-Dae Gong
Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3- b ]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Seon-Hyeong Lee, Yoon Jeon, Joon-Hee Kang, Hyonchol Jang, Kyeong-Man Hong, Dongwan Hong, Ho Lee, Soo-Youl Kim
Reply to Krupenko et al. Comment on "Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382". Cancers 13 (9) (2021)
Jae-Seon Lee, Jiwon Choi, Seon-Hyeong Lee, Joon Hee Kang, Ji Sun Ha, Hee Yeon Kim, Hyonchol Jang, Jong-In Yook, Soo-Youl Kim
Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production. Pharmaceutics 12 (11) (2020)
Dong-Keon Kim, Bomin Song, Suji Han, Hansol Jang, Seung-Hyun Bae, Hee Yeon Kim, Seon-Hyeong Lee, Seungjin Lee, Jong-Kwang Kim, Han-Seong Kim, Kyeong-Man Hong, Byung Il Lee, Hong-Duk Youn, Soo-Youl Kim, Sang Won Kang, Hyonchol Jang
Phosphorylation of OCT4 Serine 236 Inhibits Germ Cell Tumor Growth by Inducing Differentiation. Cancers 12 (9) (2020)